Yi Zou

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Breast Cancer Cells

Tyrosine Kinase

Top Venues

Journal of medicinal chemistry

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Yongling Xu, Huijie Du, Weibo Guo, Beibei Liu, Wenxin Yan, Chi Zhang, Long Qin, Jingling Huang, Hongxia Wang, Shiqi Wu, Weijie Ren, Yi Zou, Jie Wang, Qi-Hua Zhu, Yun-Gen Xu, Hongfeng Gu
Discovery of Highly Potent Small-Molecule PD-1/PD-L1 Inhibitors with a Novel Scaffold for Cancer Immunotherapy. Journal of medicinal chemistry 67 (5) (2024)
Yongling Xu, Huijie Du, Weibo Guo, Beibei Liu, Wenxin Yan, Chi Zhang, Long Qin, Jingling Huang, Hongxia Wang, Shiqi Wu, Weijie Ren, Yi Zou, Jie Wang, Qi-Hua Zhu, Yun-Gen Xu, Hongfeng Gu
Discovery of Highly Potent Small-Molecule PD-1/PD-L1 Inhibitors with a Novel Scaffold for Cancer Immunotherapy. Journal of medicinal chemistry (2024)
Zeren Sun, Lanjie Li, Bingxin Zhai, Mengxuan Hu, Lei Huang, Shihui Huang, Liu Ye, Xiangying Kong, Jie Xu, Jie Bai, Jingjie Yan, Qichen Zhou, Zheqi Hu, Yuchen Zhang, Yuhan Jiang, Yan Zhang, Zhou Qiao, Yi Zou, Yun-Gen Xu, Qi-Hua Zhu
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression. Journal of medicinal chemistry (2024)
Zeren Sun, Lanjie Li, Bingxin Zhai, Mengxuan Hu, Lei Huang, Shihui Huang, Liu Ye, Xiangying Kong, Jie Xu, Jie Bai, Jingjie Yan, Qichen Zhou, Zheqi Hu, Yuchen Zhang, Yuhan Jiang, Yan Zhang, Zhou Qiao, Yi Zou, Yun-Gen Xu, Qi-Hua Zhu
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression. Journal of medicinal chemistry 67 (6) (2024)
Zeren Sun, Lanjie Li, Bingxin Zhai, Mengxuan Hu, Lei Huang, Shihui Huang, Liu Ye, Xiangying Kong, Jie Xu, Jie Bai, Jingjie Yan, Qichen Zhou, Zheqi Hu, Yuchen Zhang, Yuhan Jiang, Yan Zhang, Zhou Qiao, Yi Zou, Yun-Gen Xu, Qi-Hua Zhu
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression. Journal of medicinal chemistry 67 (6) (2024)
Yongling Xu, Huijie Du, Weibo Guo, Beibei Liu, Wenxin Yan, Chi Zhang, Long Qin, Jingling Huang, Hongxia Wang, Shiqi Wu, Weijie Ren, Yi Zou, Jie Wang, Qi-Hua Zhu, Yun-Gen Xu, Hongfeng Gu
Discovery of Highly Potent Small-Molecule PD-1/PD-L1 Inhibitors with a Novel Scaffold for Cancer Immunotherapy. Journal of medicinal chemistry 67 (5) (2024)
Hongfeng Gu, Wenxin Yan, Jieping Yang, Beibei Liu, Xiaolin Zhao, Hongxia Wang, Wenbo Xu, Chenghao Wang, Yang Chen, Qiuyi Dong, Qi-Hua Zhu, Yun-Gen Xu, Yi Zou
Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy. Journal of medicinal chemistry (2023)
Wen Liu, Yi Zou, Kaiming Li, Haiqing Zhong, Longbo Yu, Shushan Ge, Yisheng Lai, Xianchi Dong, Qiang Xu, Wenjie Guo
Apo-Form Selective Inhibition of IDO for Tumor Immunotherapy. Journal of immunology (Baltimore, Md. : 1950) 209 (1) (2022)
Hongfeng Gu, Wenxin Yan, Yong Wang, Wenbo Xu, Lei Huang, Jieping Yang, Bingxin Zhai, Hong Wang, Yupei Su, Qi-Hua Zhu, Beibei Liu, Haiping Hao, Yi Zou, Yun-Gen Xu
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors. Journal of medicinal chemistry (2022)
Guangchao He, Sheng Wan, Yunze Wu, Zhaoxing Chu, Hui Shen, Shan Zhang, Linya Chen, Zijing Bao, Shuhui Gu, Junzhang Huang, Lei Huang, Guoqing Gong, Yi Zou, Qi-Hua Zhu, Yun-Gen Xu
Discovery of the First Selective IDO2 Inhibitor As Novel Immunotherapeutic Avenues for Rheumatoid Arthritis. Journal of medicinal chemistry 65 (21) (2022)
Shi Shi, Yu Du, Yi Zou, Jing Niu, Zeyu Cai, Xiaonan Wang, Feihuang Qiu, Yi Ding, Gengchen Yang, Yunze Wu, Yun-Gen Xu, Qi-Hua Zhu
Rational Design for Nitroreductase (NTR)-Responsive Proteolysis Targeting Chimeras (PROTACs) Selectively Targeting Tumor Tissues. Journal of medicinal chemistry 65 (6) (2022)
Hongfeng Gu, Wenxin Yan, Yong Wang, Wenbo Xu, Lei Huang, Jieping Yang, Bingxin Zhai, Hong Wang, Yupei Su, Qi-Hua Zhu, Beibei Liu, Haiping Hao, Yi Zou, Yun-Gen Xu
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors. Journal of medicinal chemistry 66 (1) (2022)
Hongfeng Gu, Wenxin Yan, Yong Wang, Wenbo Xu, Lei Huang, Jieping Yang, Bingxin Zhai, Hong Wang, Yupei Su, Qi-Hua Zhu, Beibei Liu, Haiping Hao, Yi Zou, Yun-Gen Xu
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors. Journal of medicinal chemistry 66 (1) (2022)
Hongfeng Gu, Wenxin Yan, Yong Wang, Wenbo Xu, Lei Huang, Jieping Yang, Bingxin Zhai, Hong Wang, Yupei Su, Qi-Hua Zhu, Beibei Liu, Haiping Hao, Yi Zou, Yun-Gen Xu
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors. Journal of medicinal chemistry 66 (1) (2022)
Xin He, Guangchao He, Zhaoxing Chu, Huanhuan Wu, Junjie Wang, Yiran Ge, Hui Shen, Shan Zhang, Jinxi Shan, Kewen Peng, Zhifeng Wei, Yi Zou, Yun-Gen Xu, Qi-Hua Zhu
Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A Promising Strategy for Cancer Immunotherapy. Journal of medicinal chemistry (2021)
Shu-Ping Wang, Yu Li, Shi-Hui Huang, Shi-Qi Wu, Ling-Li Gao, Qin Sun, Qian-Wen Lin, Lei Huang, Liu-Qiong Meng, Yi Zou, Qi-Hua Zhu, Yun-Gen Xu
Discovery of Potent and Novel Dual PARP/BRD4 Inhibitors for Efficient Treatment of Pancreatic Cancer. Journal of medicinal chemistry 64 (23) (2021)
Haixia Su, Yi Zou, Guofeng Chen, Huixia Dou, Hang Xie, Xiaojing Yuan, Xianglei Zhang, Naixia Zhang, Minjun Li, Yechun Xu
Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation. Journal of medicinal chemistry 63 (8) (2020)
Qiufeng Liu, Fubao Huang, Xiaojing Yuan, Kai Wang, Yi Zou, Jianhua Shen, Yechun Xu
Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2. Journal of medicinal chemistry 60 (24) (2017)